Veracyte, Inc. (VCYT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 21.78 |
| Open | 21.66 |
| Bid | 21.56 x 100 |
| Ask | 21.65 x 400 |
| Day's range | 21.58 - 22.03 |
| 52-week range | 18.61 - 30.52 |
| Volume | |
| Avg. volume | 720,756 |
| Market cap | 1.653B |
| Beta (5Y monthly) | 1.65 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.93 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 29.83 |
Business WireVeracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer
SOUTH SAN FRANCISCO, Calif., May 22, 2024--Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer.
ZacksVeracyte (VCYT) Up 6% Since Last Earnings: Will it Continue?
Investors are optimistic about Veracyte (VCYT) led by strength in the testing business and upbeat guidance.
Business WireVeracyte to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., May 15, 2024--Veracyte, Inc. (Nasdaq: VCYT) a leading cancer diagnostics company, today announced it will participate in the following investor conferences.
© 2024 Yahoo. All rights reserved.